Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Institute for Translational Medicine and Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Department of Oral Surgery and Pharmacology, University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA.
Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA; Institute for Translational Medicine and Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
J Lipid Res. 2021;62:100129. doi: 10.1016/j.jlr.2021.100129. Epub 2021 Sep 29.
The significant morbidity and mortality associated with severe acute respiratory syndrome coronavirus 2 infection has underscored the need for novel antiviral strategies. Lipids play essential roles in the viral life cycle. The lipid composition of cell membranes can influence viral entry by mediating fusion or affecting receptor conformation. Upon infection, viruses can reprogram cellular metabolism to remodel lipid membranes and fuel the production of new virions. Furthermore, several classes of lipid mediators, including eicosanoids and sphingolipids, can regulate the host immune response to viral infection. Here, we summarize the existing literature on the mechanisms through which these lipid mediators may regulate viral burden in COVID-19. Furthermore, we define the gaps in knowledge and identify the core areas in which lipids offer therapeutic promise for severe acute respiratory syndrome coronavirus 2.
严重急性呼吸综合征冠状病毒 2 感染相关的显著发病率和死亡率突出表明需要新的抗病毒策略。脂质在病毒生命周期中发挥着重要作用。细胞膜的脂质组成可以通过介导融合或影响受体构象来影响病毒进入。感染后,病毒可以重新编程细胞代谢,重塑脂膜并为新病毒粒子的产生提供燃料。此外,包括类二十烷酸和鞘脂在内的几类脂质介质可以调节宿主对病毒感染的免疫反应。在这里,我们总结了现有文献中关于这些脂质介质可能调节 COVID-19 中病毒负担的机制。此外,我们定义了知识空白,并确定了脂质为严重急性呼吸综合征冠状病毒 2 提供治疗前景的核心领域。